NCT02428192 2025-02-25
Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma
National Cancer Institute (NCI)
Phase 2 Completed
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Grupo Espanol de Investigacion en Sarcomas